Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

93 results about "Fowl adenovirus" patented technology

Group I FAdV-4 (fowl adenovirus serotype 4) vaccine

The invention provides a group I FAdV-4 (fowl adenovirus serotype 4) vaccine. An antigen of the group I FAdV-4 vaccine is an inactivated YBAV-4 virus. According to the prepared group I FAdV-4 inactivated vaccine, the immune effect of the vaccine is evaluated with a serology method and a vaccinated challenge method, a result shows that the prepared fowl adenovirus inactivated vaccine can provide effective immune protection for fowls, and the group I FAdV-4 inactivated vaccine has a good commercial development prospect.
Owner:YEBIO BIOENG OF QINGDAO

I-group 4-type fowl adenovirus DNA vaccine and application thereof

The invention provides an I-group 4-type fowl adenovirus DNA vaccine and application thereof. According to the technical scheme, based on experimental means, research finds and shows that fiber protrusions have good immunity prototypes, in this way, with 4-type fowl adenovirus fibrous protein C-terminal genes being antigen substances, codon optimization is carried out on the basis of a natural sequence, an eukaryotic expression vector pCAGGS is cloned, and the DNA vaccine pCAGoptiFAV4C is constructed. According to the researched fowl adenovirus NDA vaccine, a method of gene engineering fermentation is adopted for preparing antigens, and therefore the I-group 4-type fowl adenovirus DNA vaccine is low in cost, pure in antigen and safe to use. By the utilization of a serology method and an immunity virus attack method, the immunity effect of the vaccine is evaluated. The result shows that the vaccine can provide effective immune protection for fowl, and has good commercial development prospects. Compared with a traditional vaccine, the DNA vaccine achieves the safety of subunit vaccines and inactivated vaccines, and also has the features of simultaneous induction of humoral immunity and cellular immune response, wherein the features only belong to attenuated vaccines or recombinant vaccines.
Owner:TIANJIN RINGPU BIO TECH

Combined inactivated vaccine for avian influenza virus and fowl adenovirus

The invention provides a combined inactivated vaccine for an avian influenza virus and a fowl adenovirus. An H9 subtype avian influenza virus QDY strain and an I-group 4-type aviadenovirus YBAV-4 new strain used by the vaccine are high in TCID50 / EID50 valence and good in immunogenicity and can well withstand attacks of the H9 avian virus and various local separate viruses. The vaccine prepared by the invention is good in safety, and free of local and whole-body adverse effects caused by the vaccine. Through analysis of characters, a safety test and efficacy test data in a storage-life test, the combined vaccine is free of an obvious difference from a single vaccine of a similar product in effect, and is stable and effective; the efficacy test result proves that the antibodies of the combined vaccine and two single vaccines are kept at a high level and are faster in antibody generation of similar products; and a control group antibody is negative.
Owner:YEBIO BIOENG OF QINGDAO

F2 protein based indirect ELISA kit for detection of fowl adenovirus serotype 4 antibody

The invention discloses an F2 protein based indirect ELISA kit for detection of fowl adenovirus serotype 4 (FAdV-4) antibody. The kit includes an ELISA plate coated with a spike protein gene expression product, a positive and negative control, an HRP labeled rabbit anti-chicken secondary antibody, a sample diluent, a color development liquid and a washing liquid. The indirect ELISA kit for FAdV-4antibody established by the invention can specifically detect the FAdV-4 antibody, and does not react with anti-influenza virus (AIV) serum, anti-mardivirus (MDV) serum, anti-Newcastle disease virus (NDV) serum, anti-avian reticuloendotheliosis virus (REV) serum and SPF chicken serum (Figure 6). Therefore, the kit has good FAdV-4 specificity, and can be used for FAdV-4 infection and immune statusepidemiological investigation.
Owner:YANGZHOU UNIV

PCR detection kit for specific detection of fowl adenovirus group I and detection method thereof

The invention relates to a PCR detection kit for specific detection of fowl adenovirus group I and a detection method thereof. The detection kit comprises a fowl adenovirus group I PCR reaction liquid, 10*PCR buffer for UNG plus, hot start type DNA polymerase, dU plus dNTP mix, uracil DNA glycosylase, positive quality control serum and negative quality control serum, wherein the fowl adenovirus group I PCR reaction liquid comprises an upstream primer with a concentration of 5 micrometer and the sequence is shown as the specifications as well as a downstream primer with a concentration of 5 micrometer and the sequence is shown as the specifications. When detection is conducted through the PCR detection kit, conditions for a PCR amplified reaction are that UNG treatment is conducted at a temperature of 25 DEG C for 10 min, and predegeneration is conducted at a temperature of 95 DEG C for 2 min; degeneration is conducted at a temperature of 98 DEG C for 10 s, annealing is conducted at a temperature of 55 DEG C, extension is conducted at a temperature of 72 DEG C for 1 min, and all that are conducted for 30 work cycling; extension is conducted at a temperature of 72 DEG C for 10 min. The PCR detection kit for the specific detection of the fowl adenovirus group I has the advantages of being high in sensitivity (still positive when the reaction liquid is diluted to 1:105) and good in repeatability. The PCR detection method for the specific detection of the fowl adenovirus group I is easy, convenient and fast to operate, suitable for early diagnosis of fowl adenovirus group I virus, and can meet the demand for disease prevention and control in time.
Owner:INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI

Recombinant aviadenovirus type 4 fiber2 protein as well as preparation method and application thereof

The invention discloses a recombinant fowl adenovirus type 4 (FAdV-4) fiber2 protein as well as a preparation method and application thereof, and belongs to the technical field of gene engineering. The recombinant protein is obtained by removing 274 amino acid residues at the N end of the fowl adenovirus type 4 fiber2 protein and then recombining with the 21-55th amino acid sequence of the fowl adenovirus type 4 hexon protein; and can be used for preparing the avian adenovirus 4-type genetic engineering subunit vaccine. Aiming at the defects of poor solubility and immunogenicity of prokaryoticexpression natural fiber2 protein, the fiber2 protein coding gene is subjected to series modification, and compared with the unmodified fiber2 protein, the recombinant protein has the advantages thatthe gene coding sequence of 274 amino acid residues at the N end of the fiber2 protein is removed, and the gene coding sequences of two important antigen epitopes of the hexon protein are fused; so that the solubility and the immunogenicity are obviously improved, so that the subunit vaccine which is controllable in quality, safe and effective and can prevent highly pathogenic FAdV-4 virus infection can be prepared, and complete protection can be obtained by once immunization.
Owner:YANGTZE UNIVERSITY +1

A recombinant fowlpox virus transfer vector expressing a fowl adenovirus serotype-4 fiber2 gene, a constructing method thereof and applications of the transfer vector

The invention belongs to the technical field of biology, and mainly relates to a recombinant fowlpox virus transfer vector expressing a fowl adenovirus serotype-4 (FADV4) fiber2 gene, a constructing method thereof and applications of the transfer vector. A pMD19T-Simple vector is adopted as a base of the transfer vector. The FADV4 fiber2 gene, a lacz gene, and fowlpox virus genome replicated non-essential fragments which are LTYB and RTYB used for homologous recombination are inserted in a TA cloning site. The method includes constructing a plasmid pMD-TYB; constructing a plasmid pMD22; constructing a plasmid pMD22-lacz; constructing an intermediate vector pMD22-TYB-lacz; amplifying the FADV4 fiber2 gene; constructing a recombinant fowlpox virus transfer vector pMD22-TYB-lacz-F4; subjecting a chicken embryo Fibroblast to cotransfection with the transfer vector pMD22-TYB-lacz-F4 and a fowlpox virus; performing identification to select a positive product; performing subculture continuously; and identifying expression effects of the recombinant fowlpox virus. The recombinant fowlpox virus transfer vector constructed by the method lays a foundation for development of an efficient recombinant fowlpox virus genetic engineering living-vector vaccine expressing the fowl adenovirus serotype-4.
Owner:WENS FOODSTUFF GRP CO LTD

Genetically-engineered vaccine against fowl adenovirus type 4, and preparation method and application thereof

PendingCN111040024AStrong antigen immunityHigh antigen immunityViral antigen ingredientsVirus peptidesProtective antigenAntigen
The invention provides a genetically-engineered vaccine against fowl adenovirus type 4, and a preparation method and application thereof. According to the invention, protective antigens, namely pentonand hexon proteins of fowl adenovirus serotype 4 are connected by a linker, and are expressed by an insect cell-baculovirus expression system to form virus-like particles of fowl adenovirus type 4 onspatial conformation; an adjuvant is added; and emulsification is carried out so as to prepare the genetically-engineered vaccine against fowl adenovirus type 4. The preparation method for the vaccine provided by the invention is simple in process, capable of preparing a large amount of fowl adenovirus type 4 antigen protein, short in time consumption, high in expression quantity and beneficial to large-scale production; and the obtained genetically-engineered vaccine is good in immune effect and capable of effectively preventing infection of the fowl adenovirus type 4.
Owner:乾元浩生物股份有限公司

Heat-resistant serum 4 type fowl adenovirus genetic engineering vaccine candidate strain and construction method thereof

The invention relates to a heat-resistant serum 4 type fowl adenovirus genetic engineering vaccine candidate strain and a construction method thereof. The candidate strain is a thermal-stability newcastle disease virus (Newcastle Disease Virus) rAHR09-4F2 expressing serum 4 type fowl adenovirus spike protein 2, and the preservation number is CCTCC NO: V201932. The candidate strain is obtained through using a heat-resistant newcastle disease attenuated virus strain rAHR09 as a carrier, inserting a serum 4 type fowl adenovirus (FAdV4) spike protein (fiber2) gene between a P intergenic region andan M intergenic region, and adopting a backward heredity technique. The result of evaluating the biological characteristics and the immunoprotection efficacy of the candidate strain displays that therecombinant virus has favorable heat stability and immunogenicity and provides favorable immunoprotection on FAdV4 infection.
Owner:YANGZHOU UNIV

Primer group and kit for detecting fowl adenovirus serotype 4 (FAdV-4) as well as detection method and application of primer group

The invention discloses a primer group and a kit for detecting a fowl adenovirus serotype 4 (FAdV-4) as well as a detection method and an application of the primer group. The primer group comprises outer primers and inner primers, wherein the outer primers include F3 and B3, the inner primers include FIP and BIP, the nucleotide sequence of the F3 is shown as SEQ ID NO.1, and the nucleotide sequence of the B3 is shown as SEQ ID NO.2; and the nucleotide sequence of the FIP is shown as SEQ ID NO.3, the nucleotide sequence of the BIP is shown as SEQ ID NO.4, the FIP is a 5-end biotin labeled sequence, and the BIP is a 5-end fluorescein isothiocyanate labeled sequence. By combination of a loop-mediated isothermal amplification (LAMP) technology with a lateral flow dipstick (LFD) technology, a set of primers are designed for an important factor 52 k gene of the FAdV-4, and an LAMP-LFD rapid detection technology of the FAdV-4 is established. The LAMP-LFD kit provided by the invention is convenient to operate, safe, reliable, sensitive, efficient, good in specificity and particularly suitable for field rapid visual detection.
Owner:SICHUAN UNIV

Application of protein fiber2 and recombinant protein thereof in detection of 4-type fowl adenovirus antibody of serum

The invention discloses application of protein fiber2 and recombinant protein thereof in detection of a 4-type fowl adenovirus antibody of serum. According to the application, firstly, recombinant FAdV-4 fiber2 protein capable of being specifically combined with a 4-type fowl adenovirus specific antibody and a horse radish peroxidase labeled FAdV-4 enzyme-labeled antibody are obtained based on theprotein fiber2, and a method for specifically blocking the 4-type fowl adenovirus antibody in the serum and a detection kit are established by further using the recombinant protein as coating protein. The detection kit is high in sensitivity, high in specificity and good in stability, can be used for reflecting a neutralizing antibody level, is used for rapidly detecting the 4-type fowl adenovirus antibody in the serum, has the characteristics of simplicity in operation, high specificity, high sensitivity and low cost, can be used for simultaneously detecting a large number of samples and canbe used for monitoring an overall immunizing effect and neutralizing antibody level, so that powerful foundations and supports are provided for the diagnosis, vaccine prevention and control and the like of diseases, and the application has a very good application prospect.
Owner:新兴县国研科技有限公司 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products